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Appendix 1: Proportion of the burden of national medical expenses in Japan (by resource), fiscal year 2009. Reproduced from
“Health Insurance, An Outline of the Japanese Medical System” (Japanese Ministry of Health, Labour and Welfare; 2015).
Appendix 2: Comparison of each insurer. Reproduced from “Health Insurance, An Outline of the Japanese Medical System”
(Japanese Ministry of Health, Labour and Welfare; 2015).
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Appendix 3: Changes in health expenditure. Reproduced from Annual Health, Labour and Welfare Report 2015 (Japanese Ministry
of Health, Labour and Welfare; 2015). 
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Appendix 4: Trends in fetal deaths and fetal death rates, 1950–2015. Reproduced (with translation) from Vital Statistics (Japanese
Ministry of Health, Labour and Welfare, Statistics and Information Department; 2015).
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Appendix 5: Trends in perinatal deaths and perinatal death rates,1979–2015. Reproduced (with translation) from Vital Statistics
(Japanese Ministry of Health, Labour and Welfare, Statistics and Information Department; 2015).
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Appendix 6: Trend of life expectancies at birth. Reproduced from “Life Expectancies at Specified Ages” (Japanese Ministry of
Health, Labour and Welfare; 2014).
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Appendix 7: Contribution of each cause of death to the extension of life expectancies from 2013 to 2014. Reproduced (with
translation) from “Life Expectancies at Specified Ages” (Japanese Ministry of Health, Labour and Welfare; 2014).
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Appendix 8: Trends in age-adjusted death rates for leading causes of death by males and females, 1947–2015. Reproduced (with
translation) from Vital Statistics (Japanese Ministry of Health, Labour and Welfare, Statistics and Information Department; 2015).
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Appendix 9: Number of residency training programs by 
hospital type in 2013*
Hospital Type                                       No. of Residency Training 
                                                                       Programs, 2013
University hospital                                              13
Prefectural hospital                                            11
National hospital                                                 3
Municipal hospital                                               3
Others                                                                 5
*Based on data from Hashida (J Jpn Soc Hosp Pharm. 2013;
49[1]:39-41).
Appendix 10: Board-certified pharmacists and board-certified pharmacy specialists in Japan
Type of Specialist*                                                                                       Total No.                    Date Established
Board-Certified Pharmacotherapy Specialist†                        24  (as of June 16, 2016)               2012
Board-Certified Pharmacist in Oncology Pharmacy‡            989  (as of March 1, 2016)              2007
Board-Certified Oncology Pharmacy Specialist‡                  482  (as of June 16, 2016)               2006
Board-Certified Pharmacist in Infection Control‡                 882  (as of October 11, 2015)          2008
Board-Certified Infection Control Pharmacy Specialist‡     4253  (as of April 1, 2016)                 2006
Board-Certified Pharmacist in Psychiatric Pharmacy‡           196  (as of October 1, 2015)            2008
Board-Certified Psychiatric Pharmacy Specialist‡                   46  (as of April 1, 2016)                 2009
Board-Certified Pharmacist in Pharmacotherapy during      119  (as of October 1, 2016)            2008
Pregnancy and Lactation‡                                                       
Board-Certified Pharmacy Specialist in Pharmacotherapy        9  (as of October 1, 2016)            2009
during Pregnancy and Lactation‡                                            
Board-Certified Pharmacist in HIV Pharmacy‡                       56  (as of October 1, 2015)            2008
Board-Certified HIV Pharmacy Specialist‡                              24  (as of April 1, 2016)                 2009
*The following board-certified pharmacist specialists are approved by other organizations: Nutrition 
Support Team Specialist (Japanese Society for Parenteral and Enteral Nutrition), Board Certified Pharmacist
in Palliative Pharmacy (Japanese Society for Pharmaceutical Palliative Care and Sciences),  Infectious 
Disease Chemotherapy Pharmacist (Japanese Society of Chemotherapy), Drug Information Specialist
(Japanese Society of Drug Informatics), Healthcare Information Technologist (Japan Association for Medical
Informatics Healthcare Information Technologist Certification), Drug Safety Specialist Pharmacist (Japanese
Society of Drug Safety), Pressure Ulcer Care Pharmacist (Japanese Society of Pressure Ulcers), Certified
Pharmacist for Emergency Medicine (Japanese Society for Emergency Medicine), Certified Pharmacist 
in Pediatric Pharmacotherapy (Japan Society of Developmental Pharmacology and Therapeutics, Japan 
Pharmacists Education Center), Certified Pharmacist in Kampo Medicine (Japan Pharmacists Education
Center), Certified Diabetes Educator of Japan (Certification Board for Diabetes Educators in Japan).
†Source: Japanese Society of Pharmaceutical Health Care and Sciences (Board-Certified Pharmacists and
Board-Certified Pharmacy Specialists in Japan; www.jsphcs.jp/nintei/01.php).
‡Source: Japanese Society of Hospital Pharmacists (Board-Certified Pharmacists and Board-Certified 
Pharmacy Specialists in Japan; www.jshp.or.jp/senmon/senmon.html).
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Appendix 11: Numbers of medical professionals. Reproduced from Annual Health, Labour and Welfare Report 2015 (Japanese
Ministry of Health, Labour and Welfare; 2015).
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Appendix 12: Changes in numbers of doctors. Reproduced from Annual Health, Labour and Welfare Report 2015 (Japanese 
Ministry of Health, Labour and Welfare; 2015).
Appendix 13: Changes in numbers of nursing personnel. Reproduced from Annual Health, Labour and Welfare Report 2015
(Japanese Ministry of Health, Labour and Welfare; 2015).
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Appendix 14: Changes in the penetration rate of electronic medical chart system. Reproduced (with translation) from “Utilization
of the ICT in the Health, Medical and Care Field” (Japanese Ministry of Health, Labour and Welfare; 2015).
Appendix 15: Changes in the penetration rate of electronic medical chart system*
                                                                                     General Hospital by size of hospital                                                     
                                  General Hospital†                                                                                                          General Clinics‡
                                   (20 or more beds)         > 400 beds             200-400 beds             < 200 beds             (0 to 19 beds)
2010                                14.2%                   38.8%                22.7%                        8.9%                     14.7%
                                   (1092/7714)             (279/720)          (313/1380)                 (500/5614)          (14602/99083)
2013§                              21.9%                   57.3%                33.4%                       14.4%                    21.2%
                                   (1620/7410)             (401/700)          (440/1317)                 (779/5393)          (20797/98004)
2016                                34.2%                   77.5%                50.9%                       24.4%                    35.0%
                                   (2542/7426)             (550/710)          (682/1340)                (1310/5376)        (35178/100461)
*Reproduced (with translation) from “Current Situation of the Informatization in the Medical Field” (Japanese 
Ministry of Health, Labour and Welfare; 2015).
†General Hospital excludes psychiatric hospitals (hospitals with psychiatric wards only) and tuberculosis hospitals
(with tuberculosis wards only).
‡General clinic excludes dental clinics.
§Survey in 2013 excludes Ishinomaki and Kesennuma medical districts of Miyagi Prefecture and Fukushima 
Prefecture due to the Great East Japan Earthquake.
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Appendix 17: Flow of examination for the approval of a new drug. Reproduced from Annual Health, Labour and Welfare Report
2015 (Japanese Ministry of Health, Labour and Welfare; 2015).
Appendix 16: Classification of examinations for approval of drugs, etc. Reproduced from Annual Health, Labour and Welfare
Report 2015 (Japanese Ministry of Health, Labour and Welfare; 2015).
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Appendix 18: Diseases and persons subjected to regular vaccination. Reproduced from Annual Health, Labour and Welfare Report
2015 (Japanese Ministry of Health, Labour and Welfare; 2015).
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Appendix 19: Shift of patient care to lower cost settings. Reproduced (with translation) from Vision of Pharmacies for Patients
(Japanese Ministry of Health, Labour and Welfare; 2016).
